Skip To Main Content
Evan Barr on Muck Rack

Evan Barr

As seen in: Law.com, New York Law Journal, Law360, JD Supra, Lexology, Dealerscope, Concurrences, Employment Law Strategist, CT Lab Global Media
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Evan

Contact Evan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

DOJ’s New National Fraud Enforcement Division Pledges to Ratchet up Resources

|
By Mark Bini, Evan Barr, Rizwan A. Qureshi, Daniel Ahn, Kaela Dahan
| reedsmith.com
On August 13, 2026, Assistant Attorney General Colin M. McDonald issued a memorandum outlining the enforcement priorities of the National Fraud Enforcement Division (the “Fraud Division”)—the new standalone DOJ litigating division that has absorbed vast resources from the Criminal Division's former Fraud Section. Corporate clients should take note: this is not just a rebranding exercise.
Open in Who Shared Issue with article?

The U.S. District Court for the Eastern District of Pennsylvania grants partial summary judgment against a generic drug manufacturer on a per se Sherman Act price-fixing claim, holding it to Rule 36 admissions drawn from its $225M criminal Deferred Prosec

|
By Evan Barr, Edward Schwartz, Rafael Szmid
| Concurrences Verified
Estimated reading time: 2 min Summary On July 27, 2026, a federal judge in the Eastern District of Pennsylvania granted summary judgment in favor of a health insurance company and opt-out plaintiff in a large multidistrict antitrust litigation against a generic drug supplier and other companies alleging price-fixing violations associated with various generic drugs.
Open in Who Shared Issue with article?

Court holds company to DPA Statement of Facts in follow-on civil antitrust litigation

|
By Evan Barr, Edward Schwartz, Rafael Szmid
| reedsmith.com
Summary On July 27, 2026, a federal judge in the Eastern District of Pennsylvania granted summary judgment in favor of a health insurance company and opt-out plaintiff in a large multidistrict antitrust litigation against a generic drug supplier and other companies alleging price-fixing violations associated with various generic drugs.
Open in Who Shared Issue with article?
See all 55 articles